Investigational Drug Information for Dihydrexidine
✉ Email this page to a colleague
What is the drug development status for Dihydrexidine?
Dihydrexidine is an investigational drug.
There have been 3 clinical trials for Dihydrexidine.
The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2013.
The most common disease conditions in clinical trials are Schizotypal Personality Disorder, Personality Disorders, and Cocaine-Related Disorders. The leading clinical trial sponsors are New York State Psychiatric Institute, National Institute on Drug Abuse (NIDA), and Larry J. Siever.
Summary for Dihydrexidine
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 213 |
WIPO Patent Applications | 144 |
Japanese Patent Applications | 57 |
Clinical Trial Progress | Phase 2 (2013-04-01) |
Vendors | 0 |
Recent Clinical Trials for Dihydrexidine
Title | Sponsor | Phase |
---|---|---|
A D1 Agonist For Working Memory | National Institute of Mental Health (NIMH) | Phase 2 |
A D1 Agonist For Working Memory | New York State Psychiatric Institute | Phase 2 |
A D1 Agonist For Working Memory | Antonia New | Phase 2 |
Clinical Trial Summary for Dihydrexidine
Top disease conditions for Dihydrexidine
Top clinical trial sponsors for Dihydrexidine
US Patents for Dihydrexidine
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |